The post MSCI ACWI Nears 5-Year High as Global Markets Rally; Ex-US Outperforms the S&P 500 by 12 Percentage Points in Third Straight Year of Gains appeared on The post MSCI ACWI Nears 5-Year High as Global Markets Rally; Ex-US Outperforms the S&P 500 by 12 Percentage Points in Third Straight Year of Gains appeared on

MSCI ACWI Nears 5-Year High as Global Markets Rally; Ex-US Outperforms the S&P 500 by 12 Percentage Points in Third Straight Year of Gains

Market observers note that roughly 94% of the ACWI components are trading above the 200-day moving average, a level nearing a five-year high in line with the Kobeissi Letter analysis.

Additionally, about 87% of ACWI country markets trade above the 50-day moving average, the strongest breadth reading since July, signaling broad momentum across developed and emerging markets.

The ACWI spans 23 developed markets and 24 emerging markets, representing roughly 85% of investable equity exposure on a global scale.

Year-to-date, the ACWI has risen about 21.6%, with potential for a third consecutive annual gain. The ex-US ACWI also outperformed the S&P 500 by around 12 percentage points, the largest gap since 2009.

Source: https://en.coinotag.com/breakingnews/msci-acwi-nears-5-year-high-as-global-markets-rally-ex-us-outperforms-the-sp-500-by-12-percentage-points-in-third-straight-year-of-gains

Market Opportunity
Talus Logo
Talus Price(US)
$0,00709
$0,00709$0,00709
-2,60%
USD
Talus (US) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.